InvestorsHub Logo
Followers 511
Posts 59400
Boards Moderated 4
Alias Born 12/21/2009

Re: nodummy post# 44392

Monday, 05/27/2013 4:10:42 PM

Monday, May 27, 2013 4:10:42 PM

Post# of 220792
SKTO ~ CA NORML says plan "blatantly illegal"........

I couldn't find any info on Berkely-Bio, which SKTO says they are acquiring. So I went to the biggest MMJ advocate in CA....again.

From: xxx xxx xxx
to: normelle <ellen@canorml.org>
date: Mon, May 27, 2013 at 8:17 AM
subject: Re: [website feedback] Medical Marijuana business idea - question.
mailed-by: gmail.com

Does CA NORML know anything about Berkeley Bio-Organic Research Laboratories. Is it reputable, in your opinion? I can't find any info about it except this which calls it a major MMJ research firm.

http://ih.advfn.com/p.php?pid=nmona&article=57360530

Thanks for your time,

xxx xxx xxx

CA NORML's response. I had previously corresponded with Ellen, so I assume that's why she was copied.

from: Dale Gieringer <dale@canorml.org>
to: xxx xxx xxx
cc: Ellen Komp <ellen@canorml.org>
date: Mon, May 27, 2013 at 2:11 PM
subject: Re: [website feedback] Medical Marijuana business idea - question.

xxx xxx xxx -
Cal NORML is not familiar with Berkeley Bio-Organic Research Labs; however, we have heard of SK3 Group, and do not think they have a credible research plan. The cultivation facilities they are proposing are blatantly illegal under federal law, which will make it impossible for them to win FDA approval. While they have claimed that what they are doing is legal because they are producing CBD, not THC, the fact is that CBD is 100% illegal under federal law. It's hard to tell whether SK3 is run by fools or by hucksters; in either case, it would be foolish to put any faith in them.
- D. Gieringer, Cal NORML

Some want MORE regulations. When implemented, they will then blame
Capitalism for the consequences.....again!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.